Catalent (CTLT) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Monday Market Mixed Before Crazy, Piovitol Week | Live Stock
Kevin Travers45minutes ago
Novo Holdings Planned $16.5B Planned Acquisitions of Catalent Gets EU Inquiry
Seeking AlphaNov 4 10:10 ET
Market Chatter: Novo Holdings to Receive European Decision on Catalent Acquisition by Dec. 6
MT NewswiresNov 4 09:13 ET
Express News | Novo Seeks EU Antitrust Approval to Buy Catalent , EU Decision Due by Dec. 6, Regulatory Filing Shows
ReutersNov 4 02:50 ET
Weekly Buzz: Magnificent Mix of Market Reactions
Kevin TraversNov 1 16:26 ET
November Starts with a Climb to end Tough Week | Wall Street Today
Kevin TraversNov 1 16:03 ET

Comments

Stella-K

Jun 19 04:18

Which gets me RICH faster: Growth ETF vs. Dividend ETF Investing

I've been on the hunt for a low-risk, yet relatively high-yield investment strategy, and I'm sure many of you feel the same. 🤔While I'm hesitant to dive into stocks like $NVIDIA (NVDA.US)$ , fearing the price might be peaking and a sudden drop is imminent, I also find the stable dividends of companies like $Coca-Cola (KO.US)$ underwhelming for my limited capital. 💡 But recently, I stumbled upon the concept of diversified investing, wh...

25

Moomoo News Global

Mar 4 08:15

Columns Eli Lilly's Donanemab Nears Approval Decision, Could This Be a Turning Point in Alzheimer's Treatment?

The pharma giant $Eli Lilly and Co (LLY.US)$ is on the cusp of a significant breakthrough with its Alzheimer's drug, donanemab. Following the completion of its Phase 3 trials, donanemab is currently undergoing FDA review and has the potential to receive approval later this month. If approved, it would be the second anti-Aβ therapy for Alzheimer's disease to receive full clearance from the U.S. FD...

70

151364853

Feb 6 12:40

$Catalent (CTLT.US)$ why drop

Bigmoney Dreamer

Feb 5 22:28

$Catalent (CTLT.US)$ 👀63$ all set target

Moomoo Recap US

Feb 5 15:15

Columns Wall Street Today | Stocks Retreat as Fed in No Rush to Cut

RECAP
Stocks Fall as Yields Rise
US stocks fell as yields rose after investors tempered expectations of interest rate cuts this year. Over the weekend, Federal Reserve Chairman Jerome Powell said policymakers are worried that inflation could rear its ugly head and reaccelerate if the central bank moves too soon in lowering borrowing costs.
The $S&P 500 Index (.SPX.US)$ slipped 0.3%, while the tech-heavy $NASDAQ 100 Index (.NDX.US)$ slid 0...

Powell: Not confident rates would lower in March

24

CTLT Catalent

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target